Fluorescence-guided resection of intradural spinal tumors: a systematic review and meta-analysis

Ibrahem Albalkhi1,2, Areez Shafqat1, Othman Bin-Alamer3

  • 1College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.

Neurosurgical Review
|December 12, 2023
PubMed

Insights

Fluorescence guidance improves visualization during spinal tumor surgery, particularly for meningiomas and ependymomas. Positive intraoperative fluorescence in intramedullary tumors correlates with higher gross total resection rates.

Area of Science:

  • Neurosurgery
  • Oncology
  • Medical Imaging

Background:

  • Intradural spinal tumors pose surgical challenges due to proximity to critical neural structures.
  • Maximal tumor resection while preserving neurological function is paramount.
  • Fluorescence-guided surgery (FGS) is established for brain tumors but less so for spinal tumors.

Approach:

  • Systematic review and meta-analysis of 12 studies (552 patients) on FGS for intradural spinal tumors.
  • Included studies utilized 5-aminolevulinic acid (5-ALA) or sodium fluorescein.
  • Analysis followed PRISMA guidelines.

Key Points:

  • Meningiomas showed a 98% fluorescence rate; astrocytomas had a 70% variable rate.
  • No significant difference in gross total resection (GTR) rates between fluorescein and 5-ALA (94% vs 84%).
  • Positive intraoperative fluorescence in intramedullary tumors was linked to higher GTR rates (96% vs 73%).

Conclusions:

  • FGS enhances intraoperative visualization for select intradural spinal tumors.
  • Meningiomas and ependymomas exhibit high fluorescence rates, especially with sodium fluorescein.
  • Positive fluorescence in intramedullary tumors is associated with improved resection extent.

Related Concept Videos